These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 15491471)

  • 1. A protective merozoite protein of Plasmodium falciparum shares an epitope with surface antigens of Paramecium.
    Sehgal A; Singh NJ; Chakraborty T; Sharma S
    Parasite Immunol; 2004 May; 26(5):219-27. PubMed ID: 15491471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmodium falciparum: further characterization of a functionally active region of the merozoite invasion ligand EBA-175.
    Sim BK; Carter JM; Deal CD; Holland C; Haynes JD; Gross M
    Exp Parasitol; 1994 May; 78(3):259-68. PubMed ID: 7512929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A protective monoclonal antibody recognizes an epitope in the carboxyl-terminal cysteine-rich domain in the precursor of the major merozoite surface antigen of the rodent malarial parasite, Plasmodium yoelii.
    Burns JM; Majarian WR; Young JF; Daly TM; Long CA
    J Immunol; 1989 Oct; 143(8):2670-6. PubMed ID: 2477452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling.
    Cai Q; Peng G; Bu L; Lin Y; Zhang L; Lustigmen S; Wang H
    Vaccine; 2007 Jul; 25(28):5155-65. PubMed ID: 17548134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic peptide immunogens eliciting antibodies to Plasmodium falciparum sporozoite and merozoite surface antigens in H-2b and H-2k mice.
    Rzepczyk CM; Csurhes PA; Lord R; Matile H
    J Immunol; 1990 Oct; 145(8):2691-6. PubMed ID: 2212657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmodium falciparum: an epitope within a highly conserved region of the 47-kDa amino-terminal domain of the serine repeat antigen is a target of parasite-inhibitory antibodies.
    Fox BA; Xing-Li P; Suzue K; Horii T; Bzik DJ
    Exp Parasitol; 1997 Feb; 85(2):121-34. PubMed ID: 9030663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Universal" T helper cell determinants enhance immunogenicity of a Plasmodium falciparum merozoite surface antigen peptide.
    Kumar A; Arora R; Kaur P; Chauhan VS; Sharma P
    J Immunol; 1992 Mar; 148(5):1499-505. PubMed ID: 1371529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmodium yoelii: experimental evidences for the conserved epitopes between mouse and human malaria parasite, Plasmodium falciparum.
    Xu L; Pei X; Berzins K; Chaudhuri A
    Exp Parasitol; 2007 Jul; 116(3):214-24. PubMed ID: 17336297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune response to a synthetic peptide corresponding to an epitope of a parasitophorous vacuole membrane antigen from Plasmodium falciparum.
    Kara U; Pye D; Lord R; Pam C; Gould H; Geysen M; Jones G; Stenzel D; Kidson C; Saul A
    J Immunol; 1989 Aug; 143(4):1334-9. PubMed ID: 2473129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A protective monoclonal antibody recognizes a variant-specific epitope in the precursor of the major merozoite surface antigen of the rodent malarial parasite Plasmodium yoelii.
    Burns JM; Parke LA; Daly TM; Cavacini LA; Weidanz WP; Long CA
    J Immunol; 1989 Apr; 142(8):2835-40. PubMed ID: 2467942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies elicited by a virosomally formulated Plasmodium falciparum serine repeat antigen-5 derived peptide detect the processed 47 kDa fragment both in sporozoites and merozoites.
    Okitsu SL; Boato F; Mueller MS; Li DB; Vogel D; Westerfeld N; Zurbriggen R; Robinson JA; Pluschke G
    Peptides; 2007 Oct; 28(10):2051-60. PubMed ID: 17875342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of the C-terminal 19-kDa fragment of the Plasmodium falciparum merozoite surface protein 1 (MSP1), YMSP1(19) expressed in S. cerevisiae.
    Hui GS; Gosnell WL; Case SE; Hashiro C; Nikaido C; Hashimoto A; Kaslow DC
    J Immunol; 1994 Sep; 153(6):2544-53. PubMed ID: 8077664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of human T cell response to two Plasmodium falciparum merozoite surface antigens.
    Rzepczyk CM; Ramasamy R; Mutch DA; Ho PC; Battistutta D; Anderson KL; Parkinson D; Doran TJ; Honeyman M
    Eur J Immunol; 1989 Oct; 19(10):1797-802. PubMed ID: 2479561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmodium falciparum: gp195 tripeptide repeat-specific monoclonal antibody inhibits parasite growth in vitro.
    Locher CP; Tam LQ; Chang SP; McBride JS; Siddiqui WA
    Exp Parasitol; 1996 Oct; 84(1):74-83. PubMed ID: 8888734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel 70-kDa Triton X-114-soluble antigen of Plasmodium falciparum that contains interspecies-conserved epitopes.
    Ma HW; Ray P; Dhanda V; Das PK; Paliwal S; Sahoo N; Patra KP; Das LK; Singh B; Kironde FA
    Exp Parasitol; 1996 Aug; 83(3):322-34. PubMed ID: 8823249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of merozoite rhoptries, identification of novel rhoptry-associated proteins from Plasmodium yoelii, P. chabaudi, P. berghei, and conserved interspecies reactivity of organelles and proteins with P. falciparum rhoptry-specific antibodies.
    Sam-Yellowe TY; Del Rio RA; Fujioka H; Aikawa M; Yang JC; Yakubu Z
    Exp Parasitol; 1998 Jul; 89(3):271-84. PubMed ID: 9676705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homology building as a means to define antigenic epitopes on dihydrofolate reductase (DHFR) from Plasmodium falciparum.
    Alifrangis M; Christensen IT; Jørgensen FS; Rønn AM; Weng JE; Chen M; Bygbjerg IC; Sirawaraporn W; Palarasah Y; Koch C
    Malar J; 2004 Jun; 3():16. PubMed ID: 15193156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactivity of the human monoclonal antibody 33G2 with repeated sequences of three distinct Plasmodium falciparum antigens.
    Udomsangpetch R; Carlsson J; Wåhlin B; Holmquist G; Ozaki LS; Scherf A; Mattei D; Mercereau-Puijalon O; Uni S; Aikawa M
    J Immunol; 1989 May; 142(10):3620-6. PubMed ID: 2654292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of synthetic peptides derived from Plasmodium falciparum proteins.
    Zerpa NC; Wide A; Noda J; Bermúdez H; Pabón R; Noya OO
    Exp Parasitol; 2006 Aug; 113(4):227-34. PubMed ID: 16513113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmodium falciparum: a comparison of the activity of Pfs230-specific antibodies in an assay of transmission-blocking immunity and specific competition ELISAs.
    Roeffen W; Beckers PJ; Teelen K; Lensen T; Sauerwein RW; Meuwissen JH; Eling W
    Exp Parasitol; 1995 Feb; 80(1):15-26. PubMed ID: 7529717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.